AI assistant
Sending…
Inspire Medical Systems, Inc. — Director's Dealing 2020
May 5, 2020
31597_dirs_2020-05-04_2d5ac8c0-dd49-4cda-a8a9-33ab2b0e8e05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inspire Medical Systems, Inc. (INSP)
CIK: 0001609550
Period of Report: 2020-04-30
Reporting Person: Mead Dana G Jr. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | Stock Option (right to buy) | $71.66 | A | 3501 | Acquired | 2030-04-30 | Common Stock (3501) | Direct |
Footnotes
F1: The option vests and becomes exercisable on April 30, 2021, subject to the Reporting Person's continuous service to the Issuer through such date.
More from Inspire Medical Systems, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 20
Regulatory Filings
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Feb 25